Skip to Content
Merck
  • The IRAK4 scaffold integrates TLR4-driven TRIF and MYD88 signaling pathways.

The IRAK4 scaffold integrates TLR4-driven TRIF and MYD88 signaling pathways.

Cell reports (2022-08-18)
Milton Pereira, Danielle F Durso, Clare E Bryant, Evelyn A Kurt-Jones, Neal Silverman, Douglas T Golenbock, Ricardo T Gazzinelli
ABSTRACT

Interleukin-1 receptor-associated kinases (IRAKs) -4, -2, and -1 are involved in transducing signals from Toll-like receptors (TLRs) via the adaptor myeloid differentiation primary-response protein 88 (MYD88). How MYD88/IRAK4/2/1 complexes are formed, their redundancies, and potential non-enzymatic roles are subjects of debate. Here, we examine the hierarchical requirements for IRAK proteins in the context of TLR4 activation and confirmed that the kinase activity of IRAK4 is essential for MYD88 signaling. Surprisingly, the IRAK4 scaffold is required for activation of the E3 ubiquitin ligase TNF receptor-associated factor 6 (TRAF6) by both MYD88 and TIR domain-containing adaptor protein inducing IFN-β (TRIF), a unique adaptation in the TLR4 response. IRAK4 scaffold is, therefore, essential in integrating MYD88 and TRIF in TLR4 signaling.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Rabbit IgG (whole molecule)–Peroxidase antibody produced in goat, affinity isolated antibody
Protein G Sepharose 4 Fast Flow, Cytiva 17-0618-01, pack of 5 mL
Sigma-Aldrich
Sodium Orthovanadate, A broad spectrum potent inhibitor of protein tyrosine phosphatases.
Sigma-Aldrich
Anti-Actin antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution